Milestone Pharmaceuticals (MIST) Asset Utilization Ratio (2022)
Milestone Pharmaceuticals (MIST) posted Asset Utilization Ratio of 0.19 for Q3 2022.
Milestone Pharmaceuticals (MIST) Asset Utilization Ratio (2022) Analysis & Trends
Milestone Pharmaceuticals' Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.19 for Q3 2022.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.19 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 0.19 (changed N/A YoY) and the FY2021 annual result came in at 0.11, changed N/A from the prior year.
- Asset Utilization Ratio was 0.19 for Q3 2022 at Milestone Pharmaceuticals.
- Across five years, Asset Utilization Ratio topped out at 0.19 in Q3 2022 and bottomed at 0.19 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 0.19 |